Palantir soars 28% on earnings beat and prediction of full-year profitability

Earnings

In this article

Alex Karp, CEO of Palantir Technologies, speaks at Davos Congress Centre, the venue of the World Economic Forum (WEF) 2023, in the Alpine resort of Davos, Switzerland, January 18, 2023.
Arnd Wiegmann | Reuters

Shares of Palantir rose as much as 28% in extended trading Monday after the company released first-quarter earnings that beat analysts’ estimates and said it expects to be profitable through the end of the year.

Here’s how the company did:

  • EPS:  5 cents adjusted vs. 4 cents expected by analysts, according to Refinitiv
  • Revenue: $525 million vs. $506 million expected by analysts, according to Refinitiviv

Palantir’s revenue for the quarter increased 18% year over year, and its U.S. commercial revenue grew 26%. The software company, which is known for its work with the government, said its US commercial customer count increased 50% year over year, growing from 103 customers to 155.

The company reported its second ever quarter of positive net income on a GAAP basis, at $17 million, and in a letter to shareholders, CEO Alex Karp said the company expects to remain profitable “each quarter through the end of the year.”

Palantir said it expects to report between $528 million and $532 million in revenue during its second quarter, and between $2.19 billion and $2.24 billion for the full year.

Karp also said the demand for Palantir’s new Artificial Intelligence Platform (AIP) is “without precedent.” The company’s AIP allows commercial and government sectors to use large language models based on their own private data sets.

“We have already had hundreds of conversations with potential customers about deploying the software and are currently negotiating terms and pricing for access to the components of the platform,” he wrote.

The company will hold its quarterly call with investors at 5:00 P.M. ET Monday.

Articles You May Like

Starbucks baristas strike in three U.S. cities during pre-Christmas rush
Why the ‘great resignation’ became the ‘great stay,’ according to labor economists
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Top Wall Street analysts recommend these dividend stocks for higher returns
Number of millennial 401(k) millionaires jumps 400%: Here’s what it takes to reach seven-figure status

Leave a Reply

Your email address will not be published. Required fields are marked *